- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Hologic hires Infimed’s Greenway
Bone densitometry firm Hologic found a vice president of business development last month when it named William Greenway to the post. Greenway, formerly president and CEO of image management company InfiMed, will be responsible for the Bedford, MA,
Bone densitometry firm Hologic found a vice president of business development last month when it named William Greenway to the post. Greenway, formerly president and CEO of image management company InfiMed, will be responsible for the Bedford, MA, companys Direct Radiography technology, which it acquired last month from Sterling Diagnostic Imaging (SCAN 6/23/99).
Liverpool, NY-based InfiMed appointed William Yaeger as Greenways replacement. For the past two years, Yaeger has served as InfiMeds senior vice president of operations, and oversaw the development of the companys GoldOne Series of CCD digital x-ray acquisition systems.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
